These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 194153)

  • 21. Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils.
    Lad PM; Goldberg BJ; Smiley PA; Olson CV
    Biochim Biophys Acta; 1985 Aug; 846(2):286-95. PubMed ID: 2411298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PGI2 and PGD2 effects on cyclic AMP and human T-cell mitogenesis.
    Burchiel SW
    Prostaglandins Med; 1979 Nov; 3(5):315-20. PubMed ID: 233036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence of multiple sclerosis lymphocytes to measles infected cells.
    Frey H; Salmi A; Svedström E
    J Neurol; 1979 Mar; 220(2):99-104. PubMed ID: 87503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series.
    Schultz RM; Pavlidis NA; Stylos WA; Chirigos MA
    Science; 1978 Oct; 202(4365):320-1. PubMed ID: 694537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The fluorescence response of chlortetracycline-loaded human neutrophils is modulated by prostaglandin E1, but not by cyclic nucleotides.
    Smolen JE
    FEBS Lett; 1983 Oct; 163(1):119-23. PubMed ID: 6313429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostaglandin biosynthesis and stimulation of cyclic AMP in primary monolayer cultures of epithelial cells from mouse mammary gland.
    Burstein S; Gagnon G; Hunter SA; Maudsley DV
    Prostaglandins; 1976 Jan; 11(1):85-99. PubMed ID: 176689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte-mediated cytotoxicity to cells infected with measles virus. I. Use of in vitro infected leukocytes as autologous target cells; absence of virus-specific cytotoxic lymphocytes.
    Galama JM; Lucas CJ; Vos A
    Cell Immunol; 1978 Jul; 38(2):365-77. PubMed ID: 679280
    [No Abstract]   [Full Text] [Related]  

  • 28. Absence of the effect of ephedrine on levels of cyclic adenosine monophosphate in human lymphocytes.
    Lee TP; Reed CE
    J Allergy Clin Immunol; 1977 Aug; 60(2):141-3. PubMed ID: 194936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initiation of cell proliferation in cultured mouse fibroblasts by prostaglandin F2alpha.
    De Asua LJ; Clingan D; Rudland PS
    Proc Natl Acad Sci U S A; 1975 Jul; 72(7):2724-8. PubMed ID: 170616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of lymphoma cell death induced by cyclic AMP.
    Coffino P; Bourne HR; Tomkins GM
    Am J Pathol; 1975 Oct; 81(1):199-204. PubMed ID: 170834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of prolactin synthesis and of adenosine 3':5'-cyclic phosphate formation by prostaglandins and thyroliberin in cultured rat pituitary cells.
    Gautvik KM; Kriz M
    Biochem J; 1976 Apr; 156(1):111-7. PubMed ID: 182137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostaglandin stimulation of adenosine 3',5'-monophosphate accumulation in cultured chondrocytes in the presence or absence of parathyroid hormone.
    Kinoshita M; Kato Y; Tsuji M; Kono T; Hiraki Y; Suzuki F
    Biochim Biophys Acta; 1983 Jun; 757(3):324-31. PubMed ID: 6189524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of cyclic AMP on leucocyte inhibitory factor (LIF) production and on the inhibition of leucocyte migration.
    Lomnitzer R; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1976 Apr; 24(1):42-8. PubMed ID: 181189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of prostaglandins E1, E2 and F2alpha on neutrophil aggregation.
    O'Flaherty JT; Kreutzer DL; Ward PA
    Prostaglandins; 1979 Feb; 17(2):201-10. PubMed ID: 441431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parallel activation of cyclic AMP phosphodiesterase and cyclic AMP-dependent protein kinase in two human gut adenocarcinoma cells (HT 29 and HRT 18) in culture, by vasoactive intestinal peptide (VIP) and other effectors activating the cyclic AMP system.
    Mangeat P; Marvaldi J; Ahmed OA; Marchis-Mouren G
    Regul Pept; 1981 Mar; 1(6):397-414. PubMed ID: 6262879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissular cycli AMP levels after treatments with prostaglandins.
    Păuşescu E; Popescu MV; Dinescu I
    Physiologie; 1977; 14(1):33-7. PubMed ID: 193136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphocyte adherence in multiple sclerosis: role of the cytoskeleton and prostaglandin E.
    Dore-Duffy P; Zurier RB
    Prostaglandins Leukot Med; 1986 Aug; 23(2-3):277-87. PubMed ID: 3464022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin E2 inhibits the activation of cloned T cell hybridomas.
    Makoul GT; Robinson DR; Bhalla AK; Glimcher LH
    J Immunol; 1985 Apr; 134(4):2645-50. PubMed ID: 2857750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of cyclic AMP in modulating cytotoxic T lymphocytes. I. In-vivo-generated cytotoxic lymphocytes, but not in vitro-generated cytotoxic lymphocytes, are inhibited by cyclic AMP-active agents.
    Plaut M
    J Immunol; 1979 Aug; 123(2):692-701. PubMed ID: 222842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.